LH
NYSE · Health Care
Labcorp Holdings Inc
$267.38
+1.26 (+0.47%)
Financial Highlights (FY 2026)
Revenue
13.82B
Net Income
868.13M
Gross Margin
28.8%
Profit Margin
6.3%
Rev Growth
+5.6%
D/E Ratio
0.66
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 28.8% | 28.8% | 60.8% | 60.8% |
| Operating Margin | 9.9% | 8.9% | 15.1% | 12.9% |
| Profit Margin | 6.3% | 6.0% | 12.6% | 12.2% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 13.82B | 13.09B | 7.67B | 5.89B |
| Gross Profit | 3.97B | 3.77B | 4.67B | 3.58B |
| Operating Income | 1.37B | 1.17B | 1.16B | 761.46M |
| Net Income | 868.13M | 740.23M | 963.90M | 719.06M |
| Gross Margin | 28.8% | 28.8% | 60.8% | 60.8% |
| Operating Margin | 9.9% | 8.9% | 15.1% | 12.9% |
| Profit Margin | 6.3% | 6.0% | 12.6% | 12.2% |
| Rev Growth | +5.6% | +5.6% | +6.7% | +19.5% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 4.64B | 4.64B | 4.81B | 4.48B |
| Total Equity | 7.07B | 7.07B | 19.53B | 19.60B |
| D/E Ratio | 0.66 | 0.66 | 0.25 | 0.23 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 1.59B | 1.43B | 1.38B | 954.60M |
| Free Cash Flow | — | — | 562.68M | 560.65M |